TGFB1 and non-small cell lung carcinoma: As another small molecule inhibitor, crizotinib, a tyrosine kinase inhibitor harboring EML4‐ALK fusion, has been found to attenuate metastasis by inhibiting TGF‐β signaling in NSCLC cells without affecting cell growth [257].